People with insomnia face a 26 percent higher risk of stroke compared to those who sleep normally, according to a major European review published in the journal Sleep Medicine Reviews. Pooling data from more than a million individuals, researchers also connected sleeplessness to elevated rates of depression, dementia, and hospital admissions. However, earth.com reported that causation remains unproven, leaving scientists to treat the condition as a critical warning sign rather than a direct trigger for cardiovascular and neurological disease.
Pooled Studies Reveal Elevated Stroke and Dementia Risks
The review combined 16 earlier investigations focusing on dementia, depression, and suicide, while building three new data pools for stroke, work injuries, and hospital stays. For stroke risk specifically, the research team analyzed nine studies originating in Asia, Europe, and North America that tracked participants over periods ranging from 4 to 19 years. Among adults meeting the formal definition of insomnia—defined as trouble falling asleep, staying asleep, or waking too early despite adequate opportunity—the incidence of stroke rose by roughly 26 percent.
Dementia associations proved similarly consistent, with the strongest links pointing toward Alzheimer’s disease rather than vascular dementia. Luca Vignatelli, a neurologist and epidemiologist in Bologna, Italy, who led the work for the European Academy of Neurology, emphasized how these findings affect other areas of medicine. Insomnia deserves attention as a warning sign of the status of brain and mental health,
Vignatelli said. Co-author Stefan Seidel, a neurologist at the Medical University of Vienna, noted that the uniformity of results across distinct neurological outcomes stood out during the analysis.
Unresolved Questions Surrounding Sleeping Pills and Causation
Despite the statistical correlations, researchers caution that underlying mechanisms remain unsettled. Laboratory experiments suggest that sleep deprivation may trigger neuroinflammation and hinder the brain’s nightly clearance of proteins linked to Alzheimer’s disease, but these remain unproven hypotheses. Confounding factors complicate the data. Only one of the stroke studies evaluated the use of sleeping pills; that specific study found no clear rise in stroke risk among participants with insomnia who avoided medication, leaving open the possibility that pharmacological treatments contribute to the observed risks.
The investigation also recorded a 28-percent increase in the odds of hospital admission for any reason among roughly half a million participants, primarily older adults. Yet, because the underlying hospital studies tracked patients for only one to two years without recording admission causes, exact healthcare costs and drivers remain unclear. The authors found no definitive link between insomnia and earlier death, while data regarding work and commuting injuries proved insufficient to draw firm conclusions.
Recommended First-Line Treatments for Chronic Sleeplessness
For individuals struggling with persistent nighttime waking, Seidel advises seeking a medical evaluation to rule out underlying health conditions, medication side effects, or secondary sleep disorders. Medical guidelines generally separate occasional restless nights from chronic insomnia, which requires targeted clinical intervention. For chronic insomnia, cognitive behavioral therapy for insomnia, or CBT-I, is generally considered the first-line treatment,
Seidel told earth.com. This behavioral approach addresses the thoughts and habits that disrupt sleep without depending on pharmaceutical sedatives.
Future research must determine whether treating insomnia actively lowers the incidence of stroke, dementia, or depression. Establishing whether sleeplessness operates as a modifiable risk factor rather than a mere risk marker will require large-scale, long-term randomized controlled trials utilizing standardized diagnostic criteria across diverse global populations.
Frequently Asked Questions About Insomnia Health Risks
How is chronic insomnia clinically defined by medical researchers?
Doctors define insomnia as persistent difficulty falling asleep, staying asleep, or waking up too early, which results in noticeable daytime fatigue and impairment even when a person has adequate time and opportunity to rest.
What demographic groups experience the highest rates of insomnia?
Research indicates that women are roughly 50 percent more likely to experience insomnia than men. Nearly 30 percent of older adults report insomnia.
Does treating insomnia reduce the risk of developing a stroke or dementia?
Scientists have not yet proven whether medical or behavioral treatment for insomnia lowers the subsequent risk of stroke, dementia, or depression, as large-scale randomized trials are still needed to test this hypothesis.
More on Sleep Medicine Reviews
Keep reading